Cardiac Stem Cells: Biology and Therapeutic Applications

Principles of Regenerative Medicine

Volumn , Issue , 2011, Pages 327-346

  Selem, Sarah ^a   Hatzistergos, Konstantinos E ^a   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876511395     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381422-7.10019-7     Document Type: Chapter

References (109)

1. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007, 167:989-997.
2. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11474-11479.
3. Amado L.C., Schuleri K.H., Saliaris A.P., et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J. Am. Coll. Cardiol. 2006, 48:2116-2124.
4. Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ. Res. 1998, 83:1-14.
5. Anversa P., Kajstura J., Leri A., et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006, 113:1451-1463.
6. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
7. Assmus B., Rolf A., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ. Heart Fail. 2010, 3:89-96.
8. Barile L., Messina E., Giacomello A., et al. Endogenous cardiac stem cells. Prog. Cardiovasc. Dis. 2007, 50:31-48.
9. Bearzi C., Rota M., Hosoda T., et al. Human cardiac stem cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14068-14073.
10. Behfar A., Perez-Terzic C., Faustino R.S., et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J. Exp. Med. 2007, 204:405-420.
11. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
12. Brade T., Gessert S., Kuhl M., et al. The amphibian second heart field: Xenopus islet-1 is required for cardiovascular development. Dev. Biol. 2007, 311:297-310.
13. Buckingham M., Meilhac S., Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 2005, 6:826-835.
14. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460(7251):113-117.
15. bu-Issa R., Waldo K., Kirby M.L. Heart fields: one, two or more?. Dev. Biol. 2004, 272:281-285.
16. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002, 20:11-20.
17. Burt R.K., Loh Y., Pearce W., et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008, 299:925-936.
18. Cai C.L., Liang X., Shi Y., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell. 2003, 5:877-889.
19. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 2007, 50:1884-1893.
20. Charron F., Nemer M. GATA transcription factors and cardiac development. Semin. Cell Dev. Biol. 1999, 10:85-91.
21. Chen S., Liu Z., Tian N., et al. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J. Invasive Cardiol. 2006, 18:552-556.
22. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
23. Christoforou N., Gearhart J.D. Stem cells and their potential in cell-based cardiac therapies. Prog. Cardiovasc. Dis. 2007, 49:396-413.
24. Christoforou N., Miller R.A., Hill C.M., et al. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J. Clin. Invest 2008, 120:20-28.
25. Christoforou N., Oskouei B.N., Esteso P., Hill C.M., Zimmet J.M., Bian W., et al. Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One. 2010, 5:e11536.
26. Cyranoski D. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature 2008, 452:406-408.
27. Dai W., Hale S.L., Martin B.J., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223.
28. Dimmeler S., Burchfield J., Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2008, 28:208-216.
29. D'Ippolito G., Howard G.A., Roos B.A., et al. Isolation and characterization of marrow-isolated adult multilineage inducible (MIAMI) cells. Exp. Hematol. 2006, 34:1608-1610.
30. Dodou E., Verzi M.P., Anderson J.P., et al. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
31. Domian I.J., Chiravuri M., van der Meer P., et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 2009, 326:426-429.
32. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ. Res. 2005, 97:756-762.
33. Erbs S., Linke A., Schachinger V., et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 2007, 116:366-374.
34. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
35. Fransioli J., Bailey B., Gude N.A., et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 2008, 26:1315-1324.
36. Garry D.J., Olson E.N. A common progenitor at the heart of development. Cell 2006, 127:1101-1104.
37. Ghostine S., Carrion C., Souza L.C., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106:I131-I136.
38. Guan K., Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes?. J. Mol. Cell Cardiol. 2007, 43:377-387.
39. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54:2277-2286.
40. Hatzistergos K.E., Quevedo H., Oskouei B.N., Hu Q., Feigenbaum G.S., Margitich I.S., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 2010, 107(7):913-922.
41. Heeschen C., Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
42. Heldman A.W., Hare J.M. Cell therapy for myocardial infarction: special delivery. J. Mol. Cell Cardiol 2007, 44:473-476.
43. Hierlihy A.M., Seale P., Lobe C.G., et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 2002, 530:239-243.
44. Holmes C., Stanford W.L. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 2007, 25:1339-1347.
45. Hu T., Yamagishi H., Maeda J., et al. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 2004, 131:5491-5502.
46. Hu X., Wang J., Chen J., et al. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur. J. Cardiothorac. Surg. 2007, 31:438-443.
47. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001, 107:1395-1402.
48. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
49. Johnston P.V., Sasano T., Mills K., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
50. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004, 363:751-756.
51. Katritsis D.G., Sotiropoulou P.A., Karvouni E., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc. Interv. 2005, 65:321-329.
52. Kelly R.G., Brown N.A., Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 2001, 1:435-440.
53. Kissel C.K., Lehmann R., Assmus B., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J. Am. Coll. Cardiol. 2007, 49:2341-2349.
54. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
55. Koh G.Y., Soonpaa M.H., Klug M.G., et al. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am. J. Physiol. 1993, 264:H1727-H1733.
56. Kucia M., Reca R., Campbell F.R., et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006, 20:857-869.
57. Lam J.T., Moretti A., Laugwitz K.L. Multipotent progenitor cells in regenerative cardiovascular medicine. Pediatr. Cardiol. 2009, 30:690-698.
58. Li Z., Wu J.C., Sheikh A.Y., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007, 116:I46-I54.
59. Lim S.Y., Kim Y.S., Ahn Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc. Res. 2006, 70:530-542.
60. Maeda J., Yamagishi H., McAnally J., et al. Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev. Dyn. 2006, 235:701-710.
61. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003, 9:1195-1201.
62. Martin C.M., Meeson A.P., Robertson S.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 2004, 265:262-275.
63. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:7634-7638.
64. Martin-Rendon E., Brunskill S.J., Hyde C.J., et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur. Heart J. 2008, 15:1807-1818.
65. Matsuura K., Nagai T., Nishigaki N., et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 2004, 279:11384-11391.
66. Mazhari R., Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S21-S26.
67. Meilhac S.M., Esner M., Kelly R.G., et al. The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev. Cell 2004, 6:685-698.
68. Meissner K., Heydrich B., Jedlitschky G., et al. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. J. Histochem. Cytochem. 2006, 54:215-221.
69. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
70. Menasche P. Skeletal myoblasts for cardiac repair: Act II?. J. Am. Coll. Cardiol. 2008, 52:1881-1883.
71. Messina E., De A.L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 2004, 95:911-921.
72. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
73. Mirotsou M., Zhang Z., Deb A., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1643-1648.
74. Moretti A., Bellin M., Jung C.B., Thies T.M., Takashima Y., Bernshausen A., et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 2010, 24(3):700-711.
75. Moretti A., Caron L., Nakano A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
76. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart 2007, 93:1137-1146.
77. Nagaya N., Kangawa K., Itoh T., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112:1128-1135.
78. Nakanishi C., Yamagishi M., Yamahara K., et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008, 374:11-16.
79. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 2004, 10:494-501.
80. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:12313-12318.
81. Okada M., Payne T.R., Zheng B., et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol. 2008, 52:1869-1880.
82. Okita K., Nakagawa M., Hyenjong H., et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
83. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
84. Oshima H., Payne T.R., Urish K.L., et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol. Ther. 2005, 12:1130-1141.
85. Park E.J., Ogden L.A., Talbot A., et al. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 2006, 133:2419-2433.
86. Pfister O., Oikonomopoulos A., Sereti K.I., et al. Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ. Res. 2008, 103:825-835.
87. Phan D., Rasmussen T.L., Nakagawa O., et al. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart. Development 2005, 132:2669-2678.
88. Prall O.W., Menon M.K., Solloway M.J., et al. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128:947-959.
89. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N. Engl. J. Med. 2002, 346:5-15.
90. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U.S.A., 106, 14022-14027.
91. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell Cardiol. 2002, 34:241-249.
92. Roncalli J., Tongers J., Renault M.A., et al. Biological approaches to ischemic tissue repair: gene- and cell-based strategies. Expert Rev. Cardiovasc. Ther. 2008, 6:653-668.
93. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 2006, 355:1210-1221.
94. Schuleri K.H., Feigenbaum G.S., Centola M., et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur. Heart J. 2009, 30:2722-2732.
95. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
96. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
97. Srivastava D., Olson E.N. A genetic blueprint for cardiac development. Nature 2000, 407:221-226.
98. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
99. Takehara N., Tsutsumi Y., Tateishi K., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J. Am. Coll. Cardiol. 2008, 52:1858-1865.
100. Tallini Y.N., Greene K.S., Craven M., et al. C-kit expression identifies cardiovascular precursors in the neonatal heart. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1808-1813.
101. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
102. von Both I., Silvestri C., Erdemir T., et al. Foxh1 is essential for development of the anterior heart field. Dev. Cell 2004, 7:331-345.
103. Vulliet P.R., Greeley M., Halloran S.M., et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004, 363:783-784.
104. Wu S.M., Fujiwara Y., Cibulsky S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
105. Yang L., Soonpaa M.H., Adler E.D., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
106. Yi B.A., Wernet O., Chien K.R. Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J. Clin. Invest. 2010, 120:20-28.
107. Yoon P.D., Kao R.L., Magovern G.J. Myocardial regeneration. Transplanting satellite cells into damaged myocardium. Tex. Heart Inst. J. 1995, 22:119-125.
108. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
109. Zimmet J.M., Hare J.M. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res. Cardiol. 2005, 100:471-481.